SELLAS Life Sciences Group, Inc. (SLS)
13.34
+0.13
(+0.98%)
USD |
NASDAQ |
Aug 31, 16:00
13.33
-0.01
(-0.07%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Long Term Debt (Quarterly) : 0.157M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.157M |
| March 31, 2026 | 0.309M |
| December 31, 2025 | 0.457M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.157M |
| March 31, 2025 | 0.309M |
| December 31, 2024 | 0.457M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.161M |
| March 31, 2024 | 0.313M |
| December 31, 2023 | 0.46M |
| September 30, 2023 | 0.178M |
| June 30, 2023 | 0.302M |
| March 31, 2023 | 0.422M |
| December 31, 2022 | 0.573M |
| September 30, 2022 | 0.68M |
| June 30, 2022 | 0.783M |
| March 31, 2022 | 0.883M |
| December 31, 2021 | 0.61M |
| September 30, 2021 | 0.667M |
| June 30, 2021 | 0.721M |
| March 31, 2021 | 0.775M |
| December 31, 2020 | 0.825M |
| September 30, 2020 | 0.873M |
| June 30, 2020 | 0.918M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.028M |
| March 31, 2019 | 0.112M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 7.638M |
| March 31, 2018 | 9.676M |
| December 31, 2017 | 10.99M |
| September 30, 2017 | 12.17M |
| June 30, 2017 | 13.02M |
| March 31, 2017 | 12.60M |
| December 31, 2016 | 16.40M |
| September 30, 2016 | 23.72M |
| June 30, 2016 | 23.16M |
| March 31, 2016 | 3.74M |
| December 31, 2015 | 4.739M |
| September 30, 2015 | 5.692M |
| June 30, 2015 | 6.625M |
| March 31, 2015 | 7.528M |
| December 31, 2014 | 8.402M |
| September 30, 2014 | 9.283M |
| June 30, 2014 | 10.10M |
| March 31, 2014 | 10.01M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Savara, Inc. | 30.11M |
| Lite Strategy, Inc. | 0.00 |
| AbbVie, Inc. | 70.82B |
| Marker Therapeutics, Inc. | 0.00 |
| Rezolute, Inc. | 0.438M |